Emerging research suggests that shifts in gut bacteria could precede traditional blood glucose markers, offering potential early warning signs for type 2 diabetes risk.
Researchers are increasingly looking beyond blood sugar alone for early signs of type 2 diabetes risk. According to findings presented at the European Association for the Study of Diabetes annual meeting, people with glucose levels still in the normal range may already show a distinct gut-microbe pattern linked to insulin resistance, the condition in which the body does not respond properly to insulin and which can precede diabetes. The work, based on data from more than 229,000 adults in the US and UK, suggests that changes in the gut may emerge before standard blood tests turn abnormal.
The broader scientific picture points in the same direction. A study in JAMA Network Open found that gut microbial diversity was associated with insulin resistance and type 2 diabetes, while research in Nature has shown that the microbiota’s role in carbohydrate metabolism can influence insulin resistance. Other work published in Cell Metabolism reported that gut bacteria composition shifted alongside worsening glycaemic status, with fewer butyrate-producing bacteria seen in prediabetes and diabetes. Together, these studies reinforce the idea that the gut microbiome may be part of the chain of events that leads to metabolic disease.
The new presentation went a step further by suggesting that the microbial signature may be visible even before prediabetes is diagnosed. Among more than 135,000 participants with normal blood glucose, those whose sugar levels stayed higher for longer after eating were more likely to carry bacteria associated with diabetes, and the microbial differences became more pronounced as insulin resistance increased. That matters because insulin resistance can develop well before glucose crosses the threshold used to diagnose diabetes. Gabriel Baldanzi of the University of Trento said the findings support the long-standing view that diet and physical activity can help prevent or delay type 2 diabetes.
Still, the research should not be mistaken for a green light to swap established screening for consumer microbiome tests. The study was presented as conference research, not a completed clinical trial, and the authors said microbiome analysis is not a substitute for blood-based checks such as A1C, fasting glucose or glucose-tolerance testing. Several researchers involved in the work also disclosed ties to ZOE, including employment, consulting and ownership interests. For now, the practical message remains familiar: regular exercise, weight control and other lifestyle changes are still the most reliable tools for lowering diabetes risk.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
